Literature DB >> 6753162

Hematin therapy for the porphyric attack.

C A Pierach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6753162     DOI： 10.1055/s-2008-1040702

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  5 in total

Review 1.  Management of attacks of acute porphyria.

Authors:  A C Laiwah; K E McColl
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

2.  Effects of repeated intravenous administration of haem arginate upon hepatic metabolism of foreign compounds in rats and dogs.

Authors:  O Tokola
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

3.  Immune stimulatory and anti-tumour properties of haemin.

Authors:  A Tsuji; J Wang; K H Stenzel; A Novogrodsky
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

4.  Heme acts through the Bach1b/Nrf2a-MafK pathway to regulate exocrine peptidase precursor genes in porphyric zebrafish.

Authors:  Shuqing Zhang; Minrui Xu; Jian Huang; Lili Tang; Yanqing Zhang; Jingyao Wu; Shuo Lin; Han Wang
Journal:  Dis Model Mech       Date:  2014-03-20       Impact factor: 5.758

Review 5.  Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know.

Authors:  Petro E Petrides
Journal:  Diagnostics (Basel)       Date:  2022-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.